Macrogenics (MGNX) Misses Q2 EPS by 23c

Macrogenics (NASDAQ: MGNX) reported Q2 EPS of ($0.89), $0.23 worse than the analyst estimate of ($0.66). Revenue for the quarter came in at $10.79 million versus the consensus estimate of $20.94 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• SpaceX signs compute deal with Reflection - CNBC
• Amazon (AMZN) call put ratio 1.9 calls to 1 put as share price down 4.1%
• Expeditionary Energy's Future: Fewer Convoys, More Control